Thomas Sabia
Corporate Officer/Principal at QUINCE THERAPEUTICS, INC.
Profile
Thomas Sabia is currently the Chief Commercial Officer at Quince Therapeutics, Inc. He previously held the same position at EryDel SpA from 2022 to 2023.
Mr. Sabia has an undergraduate degree and an MBA from Salisbury State University.
Thomas Sabia active positions
Companies | Position | Start |
---|---|---|
QUINCE THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-09-30 |
Former positions of Thomas Sabia
Companies | Position | End |
---|---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 2023-09-30 |
Training of Thomas Sabia
Salisbury State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
QUINCE THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Stock Market
- Insiders
- Thomas Sabia